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Abstract: Interaction between host cells and microbes is known as crosstalk. Among other 
mechanisms, this takes place when certain molecules of the micro-organisms are recognized 
by the toll-like receptors (TLRs) in the body cells, mainly in the intestinal epithelial cells 
and in the immune cells. TLRs belong to the pattern-recognition receptors and represent the 
first line of defense against pathogens, playing a pivotal role in both innate and adaptive 
immunity. Dysregulation in the activity of such receptors can lead to the development of 
chronic and severe inflammation as well as immunological disorders. Among components 
present in the diet, flavonoids have been suggested as antioxidant dietary factors able to 
modulate TLR-mediated signaling pathways. This review focuses on the molecular targets 
involved in the modulatory action of flavonoids on TLR-mediated signaling pathways, 
providing an overview of the mechanisms involved in such action. Particular flavonoids have 
been able to modify the composition of the microbiota, to modulate TLR gene and protein 
expression, and to regulate the downstream signaling molecules involved in the TLR 
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pathway. These synergistic mechanisms suggest the role of some flavonoids in the 
preventive effect on certain chronic diseases. 
Keywords: TLR; polyphenols; inflammation; vegetables; intracellular signaling 
 
1. Host-Microbiota Crosstalk and Dietary Factors 
1.1. Interaction between Microbiota and the Host 
The intestinal mucosa is constantly interacting with a high load of antigens, which comprises, besides 
those from food, those derived from microbes, both commensal microbiota and invading pathogens. For 
this reason, the gastrointestinal tract contains the intestinal epithelial cells (IEC) that act as a physical 
barrier, and the largest part of the immune system: the gut-associated lymphoid tissue (GALT), with 
approximately 70% of the body immune cells [1]. The main function of the IEC and immune cells 
located in the intestine is to discriminate precisely between the potential harmful antigens, and then 
mounting an effective immune response, and those which are innocuous and therefore do not require 
counteraction from the host, a process known as oral tolerance [2]. The key and ineludible first action in 
this discrimination consists of the recognition of microbial components in the intestine. 
The microbial interaction with host cells (both immune and non-immune cells) is known as crosstalk. 
Certain microbiota components can be recognized through the pattern-recognition receptors (PRRs). 
These are host innate immune receptors involved in the detection of pathogens that recognize conserved 
molecular structures known as pathogen-associated molecular patterns (PAMPs) as well as  
microbe-associated molecular patterns (MAMPs) (host-commensal interactions) and induce the 
production of innate effector molecules. These can be located on the cell membrane or in the cytosol 
joining to bacterial-surface-exposed structures or nucleic acids, respectively. The cytosolic receptors are 
composed of two major families: the nucleotide oligomerization domain (NOD)—like receptors (NLRs) 
such as NOD1, NOD2 and NLRP1, and the retinoic acid inducible gene I (RIG-1)—like receptors 
(RLRs) which recognizes viral RNAs. The cell membranes’ PRRs include toll-like receptors (TLRs) 
that may reside outside the cell or in specialized vesicular compartments (endosomes) where they detect 
DNA and RNA derived from viruses and bacteria [3]. 
PRRs represent the first line of host defense against pathogens, play a pivotal role in both innate and 
adaptive immunity and can lead to the subsequent inflammatory process. Their activation results not 
only in local mucosal immunity but also in systemic immune responses. In this sense, small amounts of 
MAMPS and exogenous antigens from microbes are handled in a homeostatic manner when the PRRs 
are operating in a healthy manner, leading then to an appropriate pathway activation and balanced 
mediators secretion. However, dysregulation in the activity of such receptors can lead to the development 
of chronic and severe inflammation as well as immunological disorders, including septic shock, 
atherosclerosis, diabetes and cancer [4,5]. 
It can be of importance to study the influence of diet in such initial activation. Among components 
present in the diet, polyphenols, mainly flavonoids, have been suggested as dietary factors able to 
modulate TLR-mediated signaling pathways [5]. 
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1.2. Toll-Like Receptors 
Each host TLR recognizes distinct PAMPs derived from various microbial pathogens including 
viruses, bacteria, protozoa and fungi. However, besides their microbial-sensing activity, TLRs also play 
a role in the recognition of endogenous intracellular molecules released by activated or necrotic cells 
and extracellular matrix, called damage-associated molecular patterns (DAMPs), which also lead to an 
inflammatory response which is needed to promote tissue repair [6]. 
In addition, TLR activation induces the expression of many immune and inflammatory genes via the 
stimulation of nuclear factor κB (NF-κB) and mitogen-activated protein kinases (MAPKs), such as 
extracellular signal-regulated kinase (ERK), p38 and c-jun N-terminal kinase (JNK) [7]. Generally,  
NF-κB and MAPKs, involving p38MAPK or JNK, contribute in activating some proinflammatory 
cytokines [8,9], whereas activation of ERK promotes cell survival [10]. 
There are 11 human TLRs identified so far, divided into three groups according to the target in which 
they interact: lipids and lipopeptides (TLR1, 2, 4 and 6), proteins (TLR5) and nucleic acids (TLR3, 7, 8 
and 9). TLR1 forms heterodimers with TLR2 (TLR1/2) and recognizes triacyl lipopeptides. TLR2 in 
concert with TLR1 or TLR6 recognizes a wide variety of PAMPs, including peptidoglycan, lipopeptides 
and lipoproteins of Gram-negative bacteria, mycoplasma lipopeptides and fungal zymosan. TLR6 in 
association with TLR2 (TLR2/6) recognizes diacyl lipopeptides. TLR4 interacts with bacterial 
lipopolysaccharide (LPS). TLR5 recognizes bacterial flagellin. TLR3 recognizes double-strand RNA, 
and TLR7 and TLR8 interact with the single-strand RNA found during viral replication. TLR9 
recognizes unmethylated deoxycytidyl-phosphate-deoxyguanosine (CpG) motifs commonly present in 
bacterial and viral genomes. Finally, human TLR11 has been reported to be non-functional because of 
the presence of a stop codon in the gene and TLR10 is able to homodimerize or heterodimerize with 
TLR1 and TLR2, but its ligand remains unknown [11]. 
Recognition of PAMPs by host TLRs triggers intracellular signaling cascades through a set of 
toll/interleukin-1 receptor (TIR) -domain-containing adaptors, including myeloid differentiation  
primary response protein 88 (MyD88), TIR domain-containing adaptor protein (TIRAP/Mal), TIR  
domain-containing adaptor inducing interferon (IFN) (TRIF/TICAM1) and TRIF-related adaptor 
molecule (TRAM/TICAM2) [12]. Each TLR recruits a specific combination of adaptors to activate 
different transcription factors, giving rise to appropriate inflammatory responses. All TLRs, with the 
exception of TLR3, share the adaptor MyD88 which recruits IL-1 receptor-associated kinase-4 (IRAK-4) 
and leads to its phosphorylation. The phosphorylated IRAK-4 then induces the phosphorylation of 
IRAK-1 [13], which, in turn, activates the tumor necrosis factor receptor-associated factor 6 (TRAF6). 
TRAF6 induces phosphorylation of the IκB kinase (IKK) complex, resulting in activation of the 
transcription factor NF-κB [14]. 
TIRAP mediates the activation of the MyD88-dependent pathway downstream of TLR2 and TLR4 [15]. 
TRIF is another adaptor molecule for TLR3 and TLR4 that produces a MyD88-independent [16,17] 
signaling pathway (TRIF-dependent). This pathway activates both NF-κB and interferon regulatory 
factor 3 (IRF3) to induce the activation of type I interferons (IFNs), and also causes delayed NF-κB 
activation mediated through the receptor-interacting protein-1 (RIP1) [17]. TRAM selectively mediates 
the TRIF-dependent pathway downstream of TLR4, but not TLR3. 
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1.3. Flavonoids 
Flavonoids are vegetal compounds that contribute to the brilliant shades of blue, scarlet and orange 
colors in leaves, flowers and fruits of plants. In addition, they are found in seeds, nuts, grains and spices, 
and in some beverages such as wine, tea and beer [18]. Chemically, flavonoids are polyphenols which 
are commonly found conjugated to sugars (as a glycosylated form) although some of them can exist as 
free aglycones [19]. 
The basic flavonoid structure is the flavan nucleus consisting of 15-carbon skeleton arranged in two 
phenyl rings bound by a three-carbon bridge commonly cyclized with oxygen, then forming three rings 
labeled A, B, C (Figure 1) [18]. The various classes of flavonoids differ in the level of oxidation and 
pattern of substitution on the C ring while individual compounds within a class differ in the pattern on 
substitution of the A and B rings. The major classes of flavonoids are flavonols, flavones, flavanones, 
isoflavones, flavanols and anthocyanidins (Figure 1). 
Figure 1. Chemical structure and representative compounds from the main families of flavonoids. 
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Flavonols are ubiquitous in plants and are found mainly in fruit skin, being the yellow and red onions 
one of the richest sources of them [20]. The flavonol class includes kaempferol, quercetin, and myricetin 
typically found as glycosides. The flavones, such as apigenin, luteolin, and baicalin, are less widely 
distributed, although substantial amounts of apigenin and luteolin have been detected in cereal grain and 
some aromatic herbs (parsley, rosemary, thyme) [18,20]. The most abundant flavanone is naringenin, 
followed by hesperidin, eriodictyol and hesperetin. They are present in especially high amounts in citrus 
fruits and usually occur as rutinosides and neohesperidosides, which differ in taste [19]. Isoflavones are 
found most often in leguminous plants with substantial quantities of daidzein and genistein occurring in 
soybean [20]. Flavanols (flavan-3-ols) include monomeric and polymeric forms called procyanidins 
(condensed tannins). Monomeric forms are catechins and gallic acid esters of catechins and  
epicatechins [19]. They are widely distributed in plants and fruits and also in tea leaves [18]. 
Anthocyanidins have a fully aromatized C ring and as a result they are positively charged. The most 
common of these natural water-soluble compounds are pelargonidin, cyaniding, delphinidin, and 
malvidin, which form conjugates with sugars and organic acids to generate a multitude of anthocyanins 
that confer a wide range of colors, ranging from orange and red to blue and purple, on fruits (specially 
in berries like strawberries, blueberries, blackberries and blackcurrants), vegetables and plants [21,22]. 
2. Objective 
There is increasing scientific evidence of a relationship between diets rich in natural antioxidants and 
the prevention of several chronic diseases. The inverse association between dietary antioxidants and 
inflammatory-like disorders is supported by several epidemiological and interventional studies [23]. 
Polyphenols, including flavonoids, are the most commonly consumed dietary antioxidants and therefore 
they may be one of the major responsible for the healthy effect of fruit-and-vegetable-enriched diets. As 
the activation of the TLR pathway constitutes the first step in the inflammatory cascade activation, and 
its deregulation can lead to severe chronic inflammation and immune disorders, it is plausible to 
hypothesize a downmodulatory action of flavonoids in the TLR-induced pathways. 
This review focuses on the molecular targets and mechanisms involved in the modulatory action of 
flavonoids on TLR-mediated signaling pathways. In this context, it aims to provide an overview of the 
three major levels involved in such action: by varying the composition of the microbiota, by modulating 
the expression and activation of TLRs and, finally, by modifying the downstream signaling pathways 
involved. The synergy of all these mechanisms may explain the high potential of flavonoids for 
preventing certain types of disorders (Figure 2). The suppression of TLR activation by flavonoids offers 
new potential interventions for ameliorating inflammatory diseases and therefore constitutes a new 
alternative to current approaches. 
3. Mechanisms of Modifying “Cross-Talk” by Flavonoids 
3.1. Influence on Growth and Composition of Microbiota 
Bacterial composition (i.e., types of MAMP and PAMP) is one of the major factors influencing TLR 
activation. In turn, dietary habits are known to modulate the composition of the gut microbiota [24]. For 
this reason, the earliest level involved in modifying the host-bacteria crosstalk by dietary flavonoids 
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involves the modification of the microbial inhabitants in the gut (Figure 2). There is evidence showing 
that several kinds of flavonoids, including flavanones, flavonols, flavanols, and isoflavones, modify the 
microbiota composition. This has been recently reviewed by Etxeberria et al. [22] who extensively 
compile the latest investigations regarding the impact of phenolic compounds, as pure chemicals or in 
the food context, on microbial communities in both in vitro and in vivo studies (in animal and  
human interventions). 
Figure 2. Overview of the mechanisms involved in the regulation of microbiota-host 
crosstalk by flavonoids. They can act at three different levels by modulating:  
(1) microbiota composition, by means of directly (flavonoid) or indirectly (metabolite) 
affecting the growth; (2) Toll-like receptor (TLR) activation, by means of acting on the 
receptor and its adaptor proteins; (3) signal transduction, by means of interfering with 
upstream and downstream kinases as well as the transcription factors involved in the 
inflammatory and immune response activation. 
 
With regard to pure flavonoids, an in vitro study tested the impact of particular flavonols (rutin, 
quercetin), flavanols (catechin) and flavanones (naringin, naringenin, hesperidin and hesperetin) on the 
growth of pure cultures of six bacteria species [25]. The author showed the dose-dependent inhibitory 
effect of the aglycones naringenin and quercetin on the growth of all bacteria species studied, which was 
stronger than that of their glycosides [25]. On the other hand, both quercetin (aglycone) and rutin 
(glycoside) significantly increased the growth of the major intestinal Bacteroidetes and Firmicutes 
phyla, with a greater increase in the former than in the latter in vitro [26]. However hesperetin and 
catechin (both aglycones) showed no or weak antibacterial activity against most of the analysed  
bacteria [25], which was later corroborated by an in vitro study evaluating the antimicrobial activity of 
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five aglycones on the growth of the probiotic Bifidobacterium adolescentis [27]. Similarly, the 
repressing and/or stimulating effect induced by flavanols, such as catechin and epicatechin, on the 
growth of certain bacteria has been reported in in vitro and batch cultures studies [28,29]. 
Besides those studies of particular flavonoids on bacteria in vitro, there are a number of studies 
showing the changes induced by flavonoid-rich foods on microbiota composition. In order to synthesize 
the available data, and based on the recompilation performed by Etxeberria et al. [22], the Figure 3 below 
classifies the number of studies or treatments with polyphenols, mainly flavonoids, into the antimicrobial 
activity or the growth-promoting effect on the more prevalent bacterial groups. 
Figure 3. Summary of the number of treatments using beverages (cocoa, tea and wine), fruits 
or vegetables (soy, pomegranate, grapes, berries and apples) rich in flavonoids and their 
impact on bacterial growth. There is a high number of studies with flavonoids (in vitro and 
in vivo) showing both antimicrobial activity (left) and growth-promoting effects (right) on 
the more prevalent bacterial groups. 
 
Globally, more than 100 experiments have shown that bacterial groups in gut microbiota are affected 
by beverages (cocoa, tea and wine) and fruits/vegetables rich in flavonoids, either showing antimicrobial 
activity or, on the contrary, promoting the growth of certain bacteria. These effects have been shown in 
all types of flavonoids. 
Concerning the effect of flavonoid-rich beverages, the intake of cocoa, which mainly contains 
epicatechin and catechin, and their polymeric forms, was able to inhibit the growth of 
Clostridium histolyticum/C. perfringens, Staphylococcus and Streptococcus genera in preclinical and 
clinical studies [28,30]. In the same way, tea flavonoids exerted an antimicrobial activity against 
selective bacterial species [31], whereas bifidogenic properties have also been attributed to them [32,33]. 
Differences in the proportion of the four major bacteria phyla in humans (Proteobacteria, Fusobacteria, 
Firmicutes, and Bacteroidetes) have been observed after a nutritional intervention with red wine which 
contains a complex mixture of polyphenols, mainly including flavanols and anthocyanins [34]. Similar 
effects have been described in rats treated for 16 weeks with wine polyphenol, which showed a 
predominant proportion of Lactobacillus and Bifidobacterium spp. [35], while controversial results were 
obtained in an in vitro batch culture [33,36]. Nevertheless, these effects were not so pronounced or even 
disappeared in humans when consuming dealcoholized red wine [34]. 
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Changes have also been observed in the Firmicutes, Actinobacteria and/or Bacteroidetes proportions 
induced by soy products, which mainly contain isoflavones, in in vitro, preclinical and clinical  
studies [37–40]. In addition, the potential modulation of gut microbiota composition by fruits has been 
thoroughly reviewed by Etxeberria et al. [22]. To date, a large amount of evidence suggests that fruits 
and their derivatives are able to significantly boost the growth of colonic-friendly bacteria, such as 
Bifidobacterium and Lactobacillus [41–44]. 
Overall, it can be summarized that the intake of flavonoids is able to modulate the composition of the 
gut microbiota, potentiating the growth of specific beneficial bacteria strains (Lactobacillus and 
Bifidobacterium in >70% of the studies), and also inhibiting the growth of certain pathogenic bacteria 
(i.e., Clostridium). It must be added that, despite the evidence described above, natural flavonoids are 
not the only responsible for this effect on gut microbiota but their metabolites are also involved. 
Flavonoids and related compounds can reach the colon where they become substrate for the microbial 
metabolism [45,46]. Indeed, intestinal bacteria have the ability to metabolize flavonoids, more or less 
efficiently, depending on their chemical structure, to simpler and more bioavailable metabolites [20,47]. 
This transformation modulates the biological activities of these compounds, which, in general, are more 
beneficial after colonic metabolism than in their original forms [45,46,48–50]. Besides the known 
biological activity of most small phenolic metabolites, several microbial catabolites from epicatechin, 
epigallocatechin or naringenin have been described possessing important antimicrobial activity, 
especially against Gram-negative species [51]. 
3.2. Modulatory Action on TLR Gene and Protein Expression 
TLR pathways can be modulated by flavonoids at different levels (Figure 2). Both TLR gene 
expression and cell membrane expression, which are directly related with TLR functionality, can be 
affected by flavonoids. Under homeostatic conditions IEC have low expression of TLR2 and TLR4, and 
therefore in a healthy context, TLR activation is low; however, in an inflammatory scenario, TLR 
expression on IEC increases and then TLR signaling is triggered [52]. 
Both in vitro studies (Table 1), using primary cells or cell lines, and in vivo studies (Table 2) have 
evidenced the influence of different classes of flavonoids on TLR gene and protein expression. The best 
results regarding the down-regulatory effect of flavonoids have been raised in the presence of TLR 
activators (i.e., LPS as an in vitro TLR4 activator) whereas lack of effect is found under non stimulatory 
conditions (i.e., in healthy animals/subjects). 
LPS-stimulated J774 macrophages treated with the flavonols engeletin and astilbin showed inhibition 
of TLR4 gene expression [53]. In addition, kaempferol-3-O-sophoroside down-regulated the cell surface 
expression of TLR2 and TLR4 in endothelial cells [54] as did quercetin in PBMC after challenge [55]. 
Flavanones as naringenin and hesperidin have shown similar effects. In particular, naringenin  
down-regulates TLR2 and TLR4 protein expression and TLR2 mRNA levels in PBMC after being 
challenged with Chlamyidia trachomatis [56]. Other assays performed in vitro in 3T3-L1 cells during 
adipocyte differentiation and in vivo in C57Bl/6j mice after a high fat diet (HFD) agree with the 
inhibitory effect of naringenin on TLR2 gene expression, although no effect was found for TLR4 [57]. 
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Table 1. Flavonoids on TLR gene and protein expression in in vitro studies. 
Flavonoid Dose Duration 1 TLR 2 Studied Target Cell (Challenge) Reference 
FLAVONOLS Engeletin 
10/50 μM 2 h 
↓ TLR4 mRNA 
J774 macrophages (LPS) [53] 
Astilbin ↓ TLR4 mRNA 
Kaempferol-3-O-
sophoroside 
– 6 h 
↓ TLR2 
Protein Endothelial cells [54] 
↓ TLR4 
Quercetin 25 μM 1 h 
↓ TLR2 
Protein PBMC [55] 
↓ TLR4 
FLAVANONES 
Naringenin 
1 μg/mL 48 h 
↓ TLR2 Protein/mRNA 
J774 macrophages (C. trachomatis) [56] 
↓ TLR4 mRNA 
Naringenin 100 μM – ↓ TLR2 mRNA 3T3L1 cells (adipocyte differentiation) [57] 
FLAVANOLS 
Epigallocatechin- 
3-gallate 
1 μM 24 h ↓ TLR4 Protein/mRNA RAW 264.7 macrophages (LPS) [58] 
Epigallocatechin- 
3-gallate 
10 μM 24 h ↔ TLR4 mRNA 
Murine bone marrow-derived  
DCs (unstimulated) 
[59]  
FLAVONES Baicalin 40/80 μM 24 + 3 h ↔ TLR1-9 mRNA Human oral keraynocytes (LPS) [60] 
Baicalin 5/10 μg/mL 0.5–6 h 
↓ TLR2 Protein/mRNA PC12 and primary rat neurons (oxygen 
glucose deprivation) 
[61] 
↓ TLR4 Protein/mRNA 
Notes: 1 Treatment duration is showed when detailed in the article, if it is not provided a (–) is showed; 2 Changes in gene expression are summarized by means of an increase (↑), decrease (↓) 
or not affected (↔) by the intervention. 
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Table 2. Flavonoids on TLR gene or protein expression in in vivo studies. 
Flavonoid Dose Duration TLR 1,2 
Studied 
Target 
Cell Reference 
FLAVONES 
Luteolin 
Daily dose of 
10 and 
25 mg/kg body 
weight 
24/78 h 
↓ TLR4 
Protein/
mRNA 
Cerebral cortex from. 
p.o 3 fed SD rats 
[62] 
↓ TLR5 
Baicalin 
One dose of 
50 mg/kg body 
weight 
4 h 
↓ TLR2 Protein/ Mice hippocampus 
cells (carotid  
arteries ligation) 
[61] 
↓ TLR4 
mRNA 
mRNA 
FLAVANONE
S Naringenin 
1% included in 
food 
16 weeks ↓ TLR2 mRNA 
Adipocytes C57Bl/6J 
mice after HFD 
[57] 
EXTRACTS 
Achyrocline 
satureoides 
(Quercetin  
and Luteolin) 
One dose of 
100 mg/kg 
1 h ↓ TLR4 Protein 
Neutrophils from p.o 
fed Wistar rats 
[63] 
Cocoa 
(Procyanidins) 
5%/10% 
included in 
food 
3 weeks 
↔ , ↓ TLR2 
mRNA 
Small intestine and 
mesenteric lymph 
nodes from p.o fed 
Wistar rats 
[64] ↔ , ↔ TLR4 
↔ ,↓ TLR7 
↔ , ↑ TLR9 
Cocoa 
(Procyanidins) 
10% 
included in 
food 
7 weeks 
↔ , ↓ , ↔ 
TLR2 
mRNA 
Small intestine, 
Peyer’s patches and 
mesenteric lymph 
nodes from p.o fed 
Wistar rats 
[65] 
↓ , ↑, ↔ TLR4 
↔ , ↓ , ↔ 
TLR7 
↔ , ↑ , ↑ TLR9 
Cocoa 
(Procyanidins) 
10% included 
in food 
6 weeks 
↔ TLR2 
mRNA 
Large intestine from 
p.o fed Wistar rats 
[30] 
↔ TLR4 
↔ TLR7 
↓ TLR9 
Orange juice 
(Flavanones) 
One dose of 
300 kcal drink 
of orange juice 
1/3/5 h 
↓ TLR2  mRNA 
Mononuclear cells 
from healthy subjects 
given high-fat high-
carbohydrate meal 
[66] 
↓ TLR4 Protein 
Orange juice 
(Flavanones) 
One dose of 
300 kcal drink 
of orange juice 
1/3/5 h ↔ TLR4 
mRNA 
Mononuclear cells 
from healthy subjects 
given high-fat high-
carbohydrate meal 
[67] 
Protein 
Notes: 1 The TLR changes are expressed as the effect on each studied tissue in the same order as mentioned on the 
cell/challenge column separated among them with a comma; 2 Changes in gene expression are summarized by means of an 
increase (↑), decrease (↓) or not affected (↔) by the intervention; 3 p.o. means per os or administration by oral route. 
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Flavones have been shown to also modulate TLR gene expression in both in vitro and in vivo studies. 
Isoliquiritigenin decreased, among other targets, the gene expression of TLR4 in RAW 264.7 
macrophage line [68], and luteolin administrated at different doses to rats was able to suppress the 
overexpression of TLR4 and TLR5 induced by ischemia in the cerebral cortex at both protein and gene 
level [62]. Baicalin added to human oral keratynocytes culture was able to down-regulate P. gingivalis 
LPS-induced expression of downstream genes associated with TLR signaling, but almost no changes 
were found in the gene expression of TLR1-9 determined by the PCR array [60]. However, in another 
study, baicalin down-regulated protein and gene expression of TLR2 and TLR4 both in vitro—PC12 
and primary neurons under oxygen glucose deprivation conditions—and in vivo—hippocampus cells 
from mice after carotid arteries ligation [61]. 
With regard to flavanols, gene and cell surface expression and total protein level of TLR4 were 
markedly reduced by the addition of epigallocatechin gallate (EGCG) to LPS-stimulated RAW 264.7 
macrophages [58]. However, it did not affect TLR4 gene expression when murine bone marrow-derived 
DCs were in resting conditions [58], which is in agreement with other studies where the flavonoid is not 
able to modify TLRs in the absence of stimulatory conditions. On the contrary, a semi-synthetic 
flavonoid called flavopiridol did not alter the TLR4 cell surface expression in LPS-stimulated RAW 
264.7 macrophages [69]. 
Some extracts rich in flavonoids have also shown an effect on TLR gene expression, mainly in in vivo 
studies. Thus, the oral treatment of Wistar rats with a hydroalcoholic extract of Achyrocline satureoides, 
a rich source of quercetin and luteolin, decreased TLR4 expression on neutrophils [63]. Wistar rats fed 
cocoa, a rich source of procyanidins among other flavonoids, showed changes in the expression of 
several TLR in different tissues of the intestinal immune system [64]: a cocoa diet induced an  
up-regulation of TLR4 and TLR9 gene expression and a down-regulation of TLR2 and TLR7 gene 
expression in Peyer’s patches (PPs) and mesenteric lymph nodes (MLNs). Conversely, in small intestine 
(SI) tissue, cocoa-fed animals showed lower values for TLR4 and TLR9 mRNA and a higher value for 
TLR2 and TLR7 [65]. However, a similar design did not show a clear effect on colonic tissue, where 
microbiota is mainly found [30]. It should be taken into account that the effects induced by these extracts 
cannot be exclusively attributed to flavonoids because other components may be acting as well (i.e., 
theobromine and fiber in cocoa). 
In humans, two interventional studies using orange juice have evaluated the increase in TLR2 and 
TLR4 mRNA and protein expression in PBMC, induced by a high-fat high-carbohydrate meal,  
in volunteers [66,67]. 
In addition to flavonoids, the effect on TLR genes or surface expression by other polyphenols has 
also been reported. Thus, curcumin decreases TLR2 gene and surface expression in immune cell lines 
(monocytic THP-1 cells and dHL-60 promyelocytic leukaemia cells) and in primary cells (peripheral 
blood polymorphonuclear neutrophils, PMN) [70], and a complement containing resveratrol prevented 
the increase in TLR4 gene expression in PBMC induced by a high-fat, high-carbohydrate meal in  
healthy subjects [71]. 
Finally, it has recently been described that TLR gene expression is subject to circadian  
rhythms [72,73] which might be related to the presence of flavonoids and other exogenous regulators of 
TLR in the diet. 
 
Antioxidants 2014, 3 660 
 
It should be also mentioned that certain flavonoids in vivo may not be the only direct responsible of 
the induced effects because indirect effects, through one or more of its microbial metabolites, might be 
also considered. However, in the in vitro studies the TLR modulation should be due to direct effects 
because the microbial metabolism is not present in such approach. Further studies with this aim should 
be developed. 
3.3. Modulatory Action in TLR Activation 
The activation of TLR intracellular signaling activation requires further processes that can also be 
targeted by flavonoids. These processes include the accumulation of lipid rafts, microdomains rich in 
cholesterol and sphingolipids that act as platforms for downstream molecules and seem to be a key factor 
in the activation of immune cells, TLR dimerization/oligomerization [74], its glycosilation and the 
participation of adaptor proteins. 
Thus, quercetin and luteolin could interact with lipid rafts [75], whereas isoliquiritigenin was able to 
suppress LPS-induced dimerization of TLR4 in a dose-dependent manner in RAW 264.7 macrophage 
cell line [68]. Polyphenols such as curcumin and resveratrol have also shown this effect [74]. With regard 
to the influence on TLR glycosilation, Helicobacter pylori infection seems to initiate the inflammatory 
cascade in gastric epithelial cells by TLR4 glycosilation, fact that has been reported suppressed  
by EGCG [47]. 
There are at least five adaptor proteins of TLR and each of these has a TIR domain (i.e., TRIF or 
MyD88), which directly or indirectly binds to the TIR domain of a TLR [76]. Flavonoids seem to 
modulate the pathways involving such adaptors, however from the literature it is difficult to ascertain 
which is the specific target affected and mainly focus on downstream molecules (Figure 4). As examples, 
isoliquiritigenin in RAW 264.7 macrophages was able to suppress the MyD88-dependent pathway (i.e., 
IRAK1 degradation) [68] whereas other in vitro studies performed in RAW 264.7 cells and also in 293T 
(human embryonic kidney cell line) showed that EGCG treatment was able to modulate both  
MyD88- and TRIF-dependent signaling pathways [77]. 
On the other hand, it has to be taken into account that TLR gene expression can be self-regulated by 
downstream molecules participating in its signaling (i.e., NF-κB) [78], which potentiates the  
down-modulatory effect of those flavonoids able to act on both targets. 
3.4. Effect on Signal Transduction Molecules 
A large number of articles can be found regarding the effect of flavonoids on the activity of different 
protein kinases that regulate various intracellular signaling cascades, such as MAPK [79,80]. For this 
reason flavonoids may also modify the downstream kinases activated after TLR triggering. Furthermore, 
oxidative stress accompanying inflammation, which also leads to MAPK activation, seems to be 
controlled by the direct action of flavonoids (Figure 4). 
The activation of MAPK engages ERK 1 and 2, JNK and p38 MAPK linked to stress stimuli, such as 
ROS overproduction or inflammation, and among other actions, this stimulation induces the 
phosphorylation of inhibitor proteins such as κB inhibitor proteins (IκBs), involved in the NF-κB 
pathway. The modulation of the activity of NF-κB, a pro-inflammatory transcription factor, is one of the 
clearest effects of certain flavonoids [81,82]. NF-κB triggers the expression of over 100 genes, many of 
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them involved in the inflammatory response [83]. NF-κB is found in the cytoplasm of non-stimulated 
cells bound to IκBs which are modulated by MAPK action. 
To date in the TLR context, the flavanols epicatechin gallate (ECG) and EGCG in human dental pulp 
fibroblast were able to block the ligand-stimulated TLR2 cell signaling pathways throughout the  
down-regulation of downstream mechanisms such as p38MAPK, SAP/JNK, ERK1/2 and 
phosphorylation of IkBa and p65 subunit of NF-κB [84]. Likewise, in DC, EGCG inhibited LPS-induced 
MAPK and NF-κB activation [59]. 
Flavones, flavonols and flavanones also modulate these kinases. Luteolin inhibits p38 MAPK [62] 
and IκB kinase activity [85] both indicating a role for this flavonoid in MyD88-dependent signaling 
pathway. Baicalin may inhibit P. gingivalis LPS-induced activation of NF-κB, p38 MAPK and  
JNK [60], and same inflammatory pathway when the study was performed in isquemic neurons [86]. 
The flavonol flavopiridol—quercetin analogue—was also able to regulate the downstream TLR2 and 
TLR3 pathways through the MyD88-dependent pathway but not the independent pathway, as was 
demonstrated by in vitro studies showing inhibition of the activation of NF-κB and MAPKs but not 
TRAF6 [69]. Flavanones such as naringenin inhibited TLR2 pathways by the modulation of IκB 
degradation and JNK phosphorylation [57], and also down-regulated the induced increase of 
phosporylation of p38 MAPK in macrophages infected with Chlamyidia trachomatis [56]. 
Foods rich in flavonoids, such as cocoa, have also shown this potential in vitro, either by their 
scavenging action or by direct interaction with the downstream kinases [87,88]. In this context, 
epicatechin, catechin and dimeric B procyanidins seem to be accumulated in the cytosol and act at the 
early stages of NF-κB activation, regulating oxidant levels and reducing IκBs phosphorylation, whereas 
cocoa dimeric procyanidins seem to be able to enter the nuclei and selectively avoid NF-κB binding  
to DNA [89]. 
Overall, it is plausible that the different structures of flavonoids and their regiospecific modifications 
in their side chains lead to different bioactivities. In this sense, Lim et al. [90] studied the effect of five 
classes of plant-derived flavonoids (flavonols, flavones, flavanones, catechins and cyanidins) on TLR2 
pathway in vitro and found differential effects on the targets studied, such as p38 MAPK and NF-κB. 
TBK1, a representative kinase found in TRIF-dependent TLR activation, participates in IRF3 
activation and type I IFNs production (Figure 4). Some flavonoids, such as EGCG, luteolin, quercetin, 
chrysiin and eriodictyol, showed inhibitory effects on this downstream kinase whereas others, such as 
naringenin and hesperitin, had no effect [77,91,92]. Moreover, isoliquiritigenin was able to suppress 
TLR3 and TLR4 agonist-induced IRF3 activations in RAW 264.7 macrophage cell line [93]. These 
results demonstrated the down-regulatory activity of certain flavonoids on the TLR3 and TLR4  
TRIF-dependent pathways (Figure 4). 
Another mechanism can be proposed as an alternative to the direct actions of flavonoids on specific 
targets of the TLR pathway. In recent years, the importance of the intracellular negative regulators of 
TLRs such as SOCS1, TOLLIP, IRAK or SIGIRR has been described [94]. In this regard, procyanidin 
dimer B2-treated macrophages up-regulate IRAK-M protein and therefore also suppress TLR4 signaling 
and phosphorylation of MAPKs such as ERK1/2, p38 and JNK [95]. Moreover, EGCG has been shown 
to up-regulate TOLLIP protein expression through a 67-kDa Laminin receptor (67LR) in 
macrophages [58] and in DCs [59]. 
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Furthermore, as previously described, DAMPs can also activate TLR pathways and it seems that 
flavonoids can target these molecules as well. For example, a DAMP known as high mobility group box 
protein 1 (HMGB1) acts as an endogen ligand of TLR2 and TLR4 when it is released to the extracellular 
compartment [6] and this release by endothelial cells is modulated by kaempferol-3-O-sophoroside [54]. 
Figure 4. Signal transduction molecules affected by the flavonoids modulatory action on 
TLR activation. Both, the MyD88 dependent (left) and independent (right) pathways are 
modulated by the effect of several flavonoids on targets from different upstream (TLR 
expression and activation; adaptors modulation) and downstream levels (kinases and 
transcription factors). Black arrows indicate stimulation of the pathway and red arrows 
indicate inhibition of the pathway. In brackets there are the references cited in the text. 
 
Overall, it can be suggested that changes in microbiota composition and TLR modulation by 
flavonoids may have also an impact on the intestinal immune activation and oral tolerance. In this sense, 
flavonoids by modulating intestinal microbiota (Section 3.1) may polarize the immune response towards 
the T-cell mediated tolerogenic pathway. At the same time the repression of the TLR signaling, which 
is associated to innate immune tolerance [96], can be also produced by flavonoids (Section 3.2). As 
certain flavonoids have been described to present immunomodulator activity by inducing changes on the 
GALT [97] and on systemic immune cells [98], as well as on regulatory T cells [99,100], we may suggest 
the possible implication of TLR signaling modulation herein described by flavonoids in such 
immunoregulatory effects. 
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4. Conclusions 
Flavonoids are able to act as exogenous regulators of TLR and therefore modulate the host-microbiota 
crosstalk. This is possible due to their ability to modulate the TLR signaling pathways at different levels. 
On one hand, flavonoids can modify the composition of the microbiota, either by direct action or through 
their microbial catabolites, acting as antimicrobial agents on certain bacterial groups or as growth 
promoters for other bacteria. On the other hand, flavonoids can modulate the gene expression, the initial 
activation process of the receptor, and the upstream and downstream signaling molecules involved in 
the TLR pathway. These synergistic mechanisms make some flavonoids interesting modulatory agents 
on TLR-mediated inflammatory responses and therefore it is plausible to think that their preventive 
effect on certain chronic diseases, associated with exacerbated TLR activation, may be at least in part 
result from TLR regulation. 
Based on these effects, we suggest that more preclinical, in vitro and animal model, studies, as well 
as human clinical trials, should be carried out with flavonoids regarding this aspect. Taking into account 
the lack of toxic effects and the high availability from natural sources, they should be considered as tools 
to counteract the increase in inflammatory-based diseases in our society. 
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